Delivery Order HHSA290201500001I-HHSA29032002T
Award Date 2/25/15
Potential Completion Date 7/5/16
Potential Value $480K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Canada
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,448.30 to AmerisourceBergen Drug Corp for supply of REXULTI 0.5 mg tablets (30-count packages). This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,400.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 mg tablets of REXULTI to treat schizophrenia and bipolar I disorder. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, completing performance within four days in September 2023. No subcontractors or set aside designations were specified. This order was placed under an existing DLA pharmaceuticals contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,661 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 30 Daytrana 30 mg/9 hour patches. Daytrana is a transdermal methylphenidate patch indicated for the treatment of attention deficit hyperactivity disorder in children aged 6 to 17 years. Under the order, Amerisourcebergen will deliver 30 patches to the DLA Troop Support Medical facility located in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,179.29 to AmerisourceBergen Drug Corp for the supply of REXULTI 3 mg tablets (30-count packages) with an ultimate completion date of July 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on July 7, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency Troop Support Medical awarded a $10,956.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 0.5 mg Rexulti tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 25, 2023 through August 28, 2023. Rexulti is an atypical antipsychotic used to treat schizophrenia and bipolar I disorder in adults. This delivery order was issued under an...
- This is a firm fixed-price delivery order contract awarded by the Agency for Healthcare Research and Quality (AHRQ) to Research Triangle Institute (RTI International), a non-profit research organization. The contract, valued at $500,000.00, is part of AHRQ's Evidence-based Practice Centers (EPC V) program and involves defining treatment-resistant depression in the Medicare population. The contract does not have a set-aside designation. RTI International, the prime contractor, has significant...
- This federal contract award, with identification number SPE2DB22D3016|SPE2DB25FAJG9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,980.95 and a completion date of January 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,314.20 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (120 mL), a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 21, 2025. The order was placed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a $2,342.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is to deliver REXULTI 2 MG TABLET 30S, a mental health medication, with an ultimate completion date of April 13, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 15mg amphetamine mixed salts extended-release capsules, a controlled substance medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $4,920.42 and a completion date of August 12, 2024. It is a firm-fixed-price delivery order contract, with no...